Nanjing Vishee Financials
| 688580 Stock | 27.26 0.11 0.40% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 113.7 M | 141.5 M |
|
|
Nanjing | Select Account or Indicator |
Understanding current and past Nanjing Vishee Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nanjing Vishee's financial statements are interrelated, with each one affecting the others. For example, an increase in Nanjing Vishee's assets may result in an increase in income on the income statement.
Please note, the presentation of Nanjing Vishee's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nanjing Vishee's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nanjing Vishee's management manipulating its earnings.
Nanjing Vishee Stock Summary
Nanjing Vishee competes with Holitech Technology, Zotye Automobile, Bus Online, Cultural Investment, and Gome Telecom. Nanjing Vishee is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE1000041Q0 |
| Business Address | Building 9, Nanjing, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.vishee.com |
| Phone | 86 40 0696 4936 |
You should never invest in Nanjing Vishee without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nanjing Stock, because this is throwing your money away. Analyzing the key information contained in Nanjing Vishee's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nanjing Vishee Key Financial Ratios
Nanjing Vishee's financial ratios allow both analysts and investors to convert raw data from Nanjing Vishee's financial statements into concise, actionable information that can be used to evaluate the performance of Nanjing Vishee over time and compare it to other companies across industries.| Revenue | 462.22 M | ||||
| Gross Profit | 321.62 M | ||||
| EBITDA | 113.44 M | ||||
| Net Income | 136.26 M | ||||
| Total Asset | 1.81 B |
Nanjing Vishee Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 1.5B | 1.6B | 1.7B | 1.8B | 2.1B | 1.2B | |
| Other Current Liab | 94.0M | 75.3M | 2.1M | 1.3M | 1.2M | 1.1M | |
| Net Tangible Assets | 230.0M | 1.4B | 1.5B | 1.4B | 1.6B | 885.8M | |
| Retained Earnings | 272.5M | 378.5M | 349.1M | 438.4M | 504.2M | 284.0M | |
| Accounts Payable | 9.9M | 9.3M | 19.7M | 18.0M | 20.7M | 13.1M | |
| Cash | 1.4B | 1.4B | 1.2B | 1.2B | 1.3B | 892.2M | |
| Other Assets | 640.7K | 1.3M | 3.4M | 85.4M | 98.2M | 103.1M | |
| Net Receivables | 12.9M | 24.3M | 21.1M | 36.6M | 42.1M | 44.2M | |
| Inventory | 37.1M | 30.4M | 34.8M | 39.9M | 45.9M | 32.7M | |
| Other Current Assets | 1.1M | 3.0M | 4.3M | 12.6M | 14.5M | 15.2M | |
| Total Liab | 129.5M | 105.7M | 155.7M | 179.3M | 206.2M | 145.3M | |
| Net Invested Capital | 1.4B | 1.5B | 1.5B | 1.6B | 1.9B | 1.1B | |
| Short Long Term Debt | 10M | 1.1M | 1.2M | 1.2M | 1.1M | 1.0M | |
| Total Current Assets | 1.4B | 1.4B | 1.3B | 1.3B | 1.4B | 950.4M | |
| Net Working Capital | 1.3B | 1.3B | 1.2B | 1.1B | 1.3B | 821.4M | |
| Intangible Assets | 20.0M | 18.8M | 106.5M | 120.6M | 138.7M | 145.6M |
Nanjing Vishee Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 22.9M | 19.8M | 12.0M | 13.8M | 15.8M | 16.0M | |
| Net Interest Income | 6.0M | 16.6M | 18.9M | 18.0M | 20.7M | 21.7M | |
| Interest Income | 6.4M | 16.8M | 19.3M | 19.3M | 22.2M | 23.3M | |
| Interest Expense | 412.8K | 184.7K | 334.0K | 1.3M | 1.5M | 1.6M | |
| Total Revenue | 378.4M | 430.0M | 321.6M | 462.2M | 531.6M | 355.7M | |
| Gross Profit | 278.6M | 321.6M | 233.1M | 331.7M | 381.5M | 261.0M | |
| Operating Income | 146.2M | 158.4M | 70.2M | 123.0M | 141.5M | 113.7M | |
| Ebit | 109.4M | 141.8M | 158.4M | 104.5M | 120.1M | 114.1M | |
| Research Development | 34.3M | 63.5M | 43.7M | 57.7M | 66.3M | 40.6M | |
| Ebitda | 123.6M | 175.3M | 208.6M | 123.3M | 141.8M | 138.4M | |
| Cost Of Revenue | 99.8M | 108.5M | 88.5M | 130.5M | 150.1M | 94.7M | |
| Income Before Tax | 166.1M | 197.4M | 105.8M | 150.0M | 172.5M | 134.2M | |
| Net Income | 143.7M | 177.8M | 93.8M | 136.3M | 156.7M | 118.6M | |
| Income Tax Expense | 15.9M | 22.9M | 19.8M | 12.0M | 13.7M | 16.1M | |
| Minority Interest | 8.7M | 5.6M | 5.0M | 275.3K | 247.8K | 235.4K |
Nanjing Vishee Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Nanjing Vishee Medical. It measures of how well Nanjing is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Nanjing Vishee brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Nanjing had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Nanjing Vishee has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (5.6M) | 6.7M | 1.8M | (5.1M) | (5.8M) | (6.1M) | |
| Investments | 1.9M | (76.8M) | (104.8M) | (164.1M) | (147.7M) | (140.3M) | |
| Change In Cash | 1.1B | (412.8K) | (113.6M) | (93.9M) | (84.5M) | (80.3M) | |
| Net Borrowings | (500K) | (5.5M) | (14M) | (1.3M) | (1.2M) | (1.2M) | |
| Free Cash Flow | 109.1M | 70.0M | (9.4M) | 716.4K | 644.8K | 612.5K | |
| Depreciation | 8.8M | 11.1M | 17.1M | 20.1M | 23.2M | 24.3M | |
| Other Non Cash Items | 614.3K | 566.7K | 2.0M | 3.2M | 3.6M | 3.8M | |
| Dividends Paid | 50.3M | 71.8M | 88.9M | 51.0M | 58.7M | 53.8M | |
| Capital Expenditures | 11.7M | 87.3M | 95.6M | 133.5M | 153.5M | 161.2M | |
| Net Income | 143.7M | 177.8M | 93.8M | 136.3M | 156.7M | 118.6M | |
| End Period Cash Flow | 1.4B | 1.4B | 1.2B | 1.2B | 1.3B | 890.5M | |
| Change To Netincome | (3.3M) | (4.1M) | (12.8M) | (19.5M) | (17.5M) | (16.6M) |
Nanjing Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanjing Vishee's current stock value. Our valuation model uses many indicators to compare Nanjing Vishee value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanjing Vishee competition to find correlations between indicators driving Nanjing Vishee's intrinsic value. More Info.Nanjing Vishee Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Nanjing Vishee Medical is roughly 2.12 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanjing Vishee by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanjing Vishee's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanjing Vishee Medical Systematic Risk
Nanjing Vishee's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nanjing Vishee volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Nanjing Vishee Medical correlated with the market. If Beta is less than 0 Nanjing Vishee generally moves in the opposite direction as compared to the market. If Nanjing Vishee Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nanjing Vishee Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nanjing Vishee is generally in the same direction as the market. If Beta > 1 Nanjing Vishee moves generally in the same direction as, but more than the movement of the benchmark.
Nanjing Vishee Medical Total Assets Over Time
Nanjing Vishee Thematic Clasifications
Nanjing Vishee Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Nanjing Vishee January 9, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nanjing Vishee help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nanjing Vishee Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nanjing Vishee Medical based on widely used predictive technical indicators. In general, we focus on analyzing Nanjing Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nanjing Vishee's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 14.03 | |||
| Value At Risk | (5.82) | |||
| Potential Upside | 4.74 |
Complementary Tools for Nanjing Stock analysis
When running Nanjing Vishee's price analysis, check to measure Nanjing Vishee's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanjing Vishee is operating at the current time. Most of Nanjing Vishee's value examination focuses on studying past and present price action to predict the probability of Nanjing Vishee's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanjing Vishee's price. Additionally, you may evaluate how the addition of Nanjing Vishee to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |